Chris Timmermann: DMT (Dimethyltryptamine), Neuroscience & the Psychedelic Experience | #25
Mind & Matter
English - June 04, 2021 04:00 - 1 hour - 63 MB - ★★★★★ - 15 ratingsScience Society & Culture science drugs psychedelics technology biotechnology innovation biology brain neuroscience startups Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Nick talks to neuroscientist & psychologist, Dr. Chris Timmermann, a scientist at the Centre for Psychedelic Research at Imperial College London. Chris led the first neuroimaging studies on the effects of the potent tryptamine psychedelic DMT on the brain. They discussed DMT and related psychedelics, including how DMT is normally consumed in both recreational and laboratory contexts, how people describe its effects, how it compares to psychedelics like psilocybin and LSD, and whether it is an endogenous compound present in our own bodies. Chris also described his research on how DMT affects patterns of brain activity, and what he hopes to learn from ongoing research, which includes extending the duration of DMT experiences from a few minutes up to 30 minutes per session.
SUPPORT
Support the show on Patreon
Organize your digital highlights & notes w/ Readwise (2 months free w/ subscription)
Start your own podcast (get $20 Amazon gift card after signup)
Buy Mind & Matter t-shirts
Connect with Nick Jikomes on Twitter
Download the podcast & follow Nick at his website
SPONSORS
Learn more about our podcast sponsor, Dosist
ABOUT Nick Jikomes:
Nick is a neuroscientist and podcast host. He is currently Director of Science & Innovation at Leafly, a technology startup in the legal cannabis industry. He received a Ph.D. in Neuroscience from Harvard University and a B.S. in Genetics from the University of Wisconsin-Madison.
Support the show (https://www.patreon.com/nickjikomes)